Thibault De La Motte Rouge

ScholarGPS® ID: 73533557439222

Affiliation

Centre Eugène Marquis, France

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

135

Predicted Citations

2,680

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
53P Description of BRCA mutated high-grade ovarian cancer demonstrating primary resistance to first-line platinum in the French national multicenter ESME database (journal article) Leary, A. \| Fouquier, A. \| Ray-Coquard, I.L. \| Rodrigues, M.J. \| Frenel, J-S. \| Sabatier, R. \| Petit, T. \| Guillemet, C. \| de la Motte Rouge, T. \| Colombo, P-E. \| ... \| Camilleri, G.M. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.103560 Cite \| Source
Phase Ib INEOV neoadjuvant trial of durvalumab +/- tremelimumab with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): Survival outcomes and immune correlates. (journal article) Leary, Alexandra \| Chardin, Laure \| Lortholary, Alain \| Asselain, Bernard \| Alexandre, Jerome \| Lebreton, Coriolan \| Savoye, Aude-Marie \| Oudard, Stephane \| Gavoille, Céline \| You, Benoit \| ... \| Pujade-Lauraine, Eric Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 5569-5569 (2024). 10.1200/JCO.2024.42.16_suppl.5569 Cite \| Source
Clinical utility of ctDNA as a tool to detect triple-negative breast cancer relapses: The CUPCAKE trial. (journal article) Bidard, Francois Clement \| Berger, Frederique \| Arnedos, Monica \| Mouret-Reynier, Marie-Ange \| Tredan, Olivier \| Sabatier, Renaud \| Jacot, William \| Massard, Vincent \| De La Motte Rouge, Thibault \| Gligorov, Joseph \| ... \| Kiavue, Nicolas Journal of Clinical Oncology, volume 42, issue 16_suppl, pages TPS1139-TPS1139 (2024). 10.1200/JCO.2024.42.16_suppl.TPS1139 Cite \| Source
Plasma‐based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer (journal article) Corné, Julien \| Quillien, Véronique \| Godey, Florence \| Cherel, Mathilde \| Cochet, Agathe \| Le Du, Fanny \| Robert, Lucie \| Bourien, Héloïse \| Brunot, Angélique \| Crouzet, Laurence \| ... \| De la Motte Rouge, Thibault Molecular Oncology (2024). 10.1002/1878-0261.13592 Cited by (2) \| Cite \| Source
21P Mass cytometry reveals a population of exhausted CD8+ T cells associated with durvalumab/tremelimumab/vinorelbine efficacy in advanced cervical cancer (iMOVIE) (journal article) Bertucci, A. \| Maby, P. \| Rochigneux, P. \| Legrand, F. \| Cropet, C. \| Frenel, J-S. \| Le Tourneau, C. \| Hervieu, A. \| Coquan, E. \| De La Motte Rouge, T. \| ... \| Chrétien, A-S. Immuno-Oncology and Technology, volume 20 (2023). 10.1016/j.iotech.2023.100490 Cite \| Source
Real-world dostarlimab use in advanced/recurrent endometrial cancer in France (journal article) Rodrigues, Manuel \| Eberst, Lauriane \| Follana, Philippe \| Gauthier, Ludiane \| Jacquemin, Virginie \| Tessier, Christophe \| El Mouaddin, Nadia \| Boudier, Philippe \| Fiteni, Frederic \| Angeli, Eurydice \| ... \| de la Motte Rouge, Thibault Bulletin du Cancer, volume 110, issue 10, pages 1041-1050 (2023). 10.1016/j.bulcan.2023.06.009 Cited by (2) \| Cite \| Source
Management of trophoblastic tumors : review of evidence, current practice, and future directions (journal article) Deleuze, Antoine \| Massard, Christophe \| Le Du, Fanny \| You, Benoit \| Lefeuvre-Plesse, Claudia \| Bolze, Pierre-Adrien \| de la Motte Rouge, Thibault Expert Review of Anticancer Therapy, volume 23, issue 7, pages 699-708 (2023). 10.1080/14737140.2023.2215438 Cited by (4) \| Cite \| Source
Immune features of ovarian tumors with a good response to neo-adjuvant chemotherapy in combination with an anti-PD-L1 alone or with an anti-CTLA4: Data from the randomized IneOV trial (a GINECO study). (journal article) Leary, Alexandra \| Chardin, Laure \| Genestie, Catherine \| Lortholary, Alain \| Alexandre, Jerome \| De La Motte Rouge, Thibault \| D'hondt, Veronique \| Floquet, Anne \| Savoye, Aude-Marie \| Delanoy, Nicolas \| ... \| Yaniz-Galende, Elisa Journal of Clinical Oncology, volume 41, issue 16_suppl, pages 5586-5586 (2023). 10.1200/JCO.2023.41.16_suppl.5586 Cite \| Source
Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients (journal article) Corné, Julien \| Quillien, Véronique \| Callens, Céline \| Portois, Pascal \| Bidard, François-Clément \| Jeannot, Emmanuelle \| Godey, Florence \| Le Du, Fanny \| Robert, Lucie \| Bourien, Héloïse \| ... \| de la Motte Rouge, Thibault Clinica Chimica Acta, volume 545 (2023). 10.1016/j.cca.2023.117366 Cited by (2) \| Cite \| Source
Efficacy of chemotherapy according to BRCA status in patients with high-grade serous ovarian carcinoma at first platinum-sensitive relapse (journal article) Brouillard-Saby, Flora \| Saint-Martin, Caroline \| Ray-Coquard, Isabelle \| Gladieff, Laurence \| Pomel, Christophe \| Colombo, Pierre-Emmanuel \| Classe, Jean-Marc \| Chevrier, Marion \| Joly, Florence \| De la Motte Rouge, Thibault \| ... \| Rodrigues, Manuel International Journal of Gynecologic Cancer, volume 33, issue 4, pages 577-584 (2023). 10.1136/ijgc-2022-003993 Cite \| Source
13O Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients: A TMRG and GINECO group study (journal article) Hanvic, B. \| Lecuru, F. \| Vanacker, H. \| Pautier, P. \| Narducci, F. \| Cherifi, F. \| Floquet, A. \| Angeles, M.A. \| Berton-Rigaud, D. \| Pomel, C. \| ... \| Ray-Coquard, I.L. ESMO Open, volume 8, issue 1, pages 101034- (2023). 10.1016/j.esmoop.2023.101034 Cite \| Source
MOVIE: a phase I, open-label, multicenter study to evaluate the safety and tolerability of metronomic vinorelbine combined with durvalumab plus tremelimumab in patients with advanced solid tumors (journal article) Vicier, C. \| Isambert, N. \| Cropet, C. \| Hamimed, M. \| Osanno, L. \| Legrand, F. \| de La Motte Rouge, T. \| Ciccolini, J. \| Gonçalves, A. ESMO Open, volume 7, issue 6, pages 100646- (2022). 10.1016/j.esmoop.2022.100646 Cited by (9) \| Cite \| Source
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations (journal article) Jacot, William \| Lusque, Amélie \| Vicier, Cécile \| Mailliez, Audrey \| de La Motte Rouge, Thibault \| Cabel, Luc \| Levy, Christelle \| Patsouris, Anne \| Desmoulins, Isabelle \| Uwer, Lionel \| ... \| Delaloge, Suzette British Journal of Cancer, volume 127, issue 11, pages 1963-1973 (2022). 10.1038/s41416-022-02003-1 Cited by (2) \| Cite \| Source
144P Development of a 6-color multiplex crystal digital PCR assay for the simultaneous detection of ESR1 and PIK3CA mutations in the plasma of metastatic breast cancer patients (journal article) Corné, J. \| Quillien, V. \| Godey, F. \| Le Du, F. \| Robert, L. \| Bourien, H. \| Brunot, A. \| Crouzet, L. \| Perrin, C. \| Lefeuvre-Plesse, C. \| ... \| De La Motte Rouge, T. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.09.145 Cite \| Source
553P Real-world data on dostarlimab in post-platinum mismatch repair deficient (dMMR)/ microsatellite instability high (MSI-H) advanced/recurrent (A/R) endometrial cancer: Descriptive analysis of the French cohort temporary authorization of use (ATU) (journal article) Rodrigues, M.J. \| Eberst, L. \| Follana, P. \| Brunel, V. \| Gauthier, L. \| Jacquemin, V.J. \| Tessier, C. \| El Mouaddin, N. \| Boudier, P. \| Fiteni, F. \| ... \| De La Motte Rouge, T. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.07.681 Cite \| Source
478P Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D): Results of the tumor mutational burden-high (TMB-h) and/or microsatellite instability-high (MSI-h) cohort of the MOVIE study (journal article) Hervieu, A. \| Guigay, J. \| Borcoman, E. \| Lavaud, P. \| Coquan, E. \| Frenel, J-S. \| De La Motte Rouge, T. \| Augereau, P. \| Cropet, C. \| Legrand, F. \| Goncalves, A. Annals of Oncology, volume 33 (2022). 10.1016/j.annonc.2022.07.606 Cited by (3) \| Cite \| Source
ODALIE Study, a retrospective analysis of a real-life cohort of patients with de novo advanced high grade epithelial ovarian cancer treated with a first-line platinum- and taxane-based chemotherapy combined with bevacizumab. (journal article) Bétrian, Sarah Lagarde \| Penault Llorca, Frederique \| Pautier, Patricia \| Joly, Florence \| Ray-Coquard, Isabelle Laure \| Costaz, Hélène \| Sauterey, Baptiste \| Floquet, Anne \| De La Motte Rouge, Thibault \| Gourgou, Sophie \| ... \| Gladieff, Laurence Journal of Clinical Oncology, volume 40, issue 16_suppl, pages e17577-e17577 (2022). 10.1200/JCO.2022.40.16_suppl.e17577 Cite \| Source
Phase Ib INEOV neoadjuvant trial of durvalumab +/- tremelimumab with platinum chemotherapy for patients (pts) with unresectable ovarian cancer (OC): Final complete resection and pathological response rates. (journal article) Leary, Alexandra \| De La Motte Rouge, Thibault \| Lortholary, Alain \| Asselain, Bernard \| Alexandre, Jerome \| Floquet, Anne \| Savoye, Aude Marie \| Delanoy, Nicolas \| Gavoille, Céline \| You, Benoit \| ... \| Pujade-Lauraine, Eric Journal of Clinical Oncology, volume 40, issue 16_suppl, pages 5557-5557 (2022). 10.1200/JCO.2022.40.16_suppl.5557 Cited by (1) \| Cite \| Source
TEDOVA/GINECO-OV244b/ENGOT-ov58 trial: Neo-epitope based vaccine OSE2101 alone or in combination with pembrolizumab versus best supportive care (BSC) as maintenance in platinum-sensitive recurrent ovarian cancer with disease control after platinum. (journal article) Leary, Alexandra \| Deluche, Elise \| Favier, Laure \| Paoletti, Xavier \| Mansi, Laura \| Tredan, Olivier \| Eberst, Lauriane \| De La Motte Rouge, Thibault \| Joly, Florence \| Lortholary, Alain \| ... \| Frenel, Jean-Sebastien Journal of Clinical Oncology, volume 40, issue 16_suppl, pages TPS5614-TPS5614 (2022). 10.1200/JCO.2022.40.16_suppl.TPS5614 Cited by (2) \| Cite \| Source
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patien (journal article) Berger, Frédérique \| Marce, Margaux \| Delaloge, Suzette \| Hardy-Bessard, Anne-Claire \| Bachelot, Thomas \| Bièche, Ivan \| Pradines, Anne \| De La Motte Rouge, Thibault \| Canon, Jean-Luc \| André, Fabrice \| ... \| Bidard, François-Clement BMJ Open, volume 12, issue 3, pages e055821- (2022). 10.1136/bmjopen-2021-055821 Cited by (28) \| Cite \| Source